Tetrazole derivatives, and anti-ulcer composition containing the same
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsMinoru Uchida, Takao Nishi, Kazuyuki Nakagawa
Life of this patent
Estimating the term…
Abstract
Tetrazole derivatives of the formula: ##STR1## wherein R.sup.1 is a lower alkykl, phenyl or a group of the formula: --S(O).sub.l --A--(X).sub.m --R.sup.3, and R.sup.2 is hydrogen, a lower alkyl, phenyl or a cycloalkyl when R.sup.1 is the group --S(O).sub.l --A--(X).sub.m --R.sup.3, or R.sup.2 is a group of the formula: --B--CO--R.sup.4 when R.sup.1 is a lower alkyl or phenyl and a pharmaceutically acceptable salt thereof, which have prophylactic or therapeutic activities against peptic and/or duodenal ulcers and are useful as an anti-ulcer drug; processes for the preparation of the tetrazole derivatives; and pharmaceutical composition containing said tetrazole derivatives.
Claims24
A tetrazole derivative of the formula:
- ##STR33## wherein R.sup.1 is a lower alkyl, phenyl or a group of the formula:
- --S(O).sub.l --A--(X).sub.m --R.sup.3, and R.sup.2 is hydrogen, a lower alkyl, phenyl or a cycloalkyl when R.sup.1 is the group --S(O).sub.l --A--(X).sub.m --R.sup.3, or R.sup.2 is a group of the formula:
- --B--CO--R.sup.4 when R.sup.1 is a lower alkyl or phenyl;
- in said formula --S--(O).sub.l --A--(X).sub.m --R.sup.3, X is --CO-- or S--(O).sub.n --, l and n are each 0, 1 or 2, m is 0 or 1, A is an alkylene having 1 to 8 carbon atoms, and R.sup.3 is a lower alkyl, a cycloalkyl, naphthyl, a group of the formula:
- ##STR34## (R.sup.5 is a lower alkyl), a phenyl(lower)alkyl which may have a halogen substituent on the phenyl ring, a pheny which may have 1 to 3 substituents selected from the group consisting of a halogen, a lower alkyl, a lower alkoxy, a lower alkanoylamino, hydroxy, carboxy and amino, a heterocyclic group-substituted lower alkyl which may have a substituent selected from a lower alkyl and amino wherein the heterocyclic group is selected from pyridyl, furyl, and thiazolyl, or a heterocyclic group containing 1 to 4 hetero atoms selected from nitrogen, oxygen and sulfur which may have 1 to 2 substituents selected from the group consisting of a lower alkyl, a halogen, carboxy, oxo, amino, a lower alkoxycarbonyl, a lower alkoxy, hydroxy, nitro, phenyl, a cycloalkyl and a lower alkylamino, wherein the heterocyclic group containing 1 to 4 hetero atoms is selected from thienyl, furyl, pyrrolyl, pyridyl, pyranyl, pyrimidyl, quinolyl, 1,2,3,4-tetrahydroquinolyl, imidazolyl, 1,3,4-thiadiazolyl, 1,3,4-oxadiazolyl, 1H-1,2,4-triazolyl, 4H-1,2,4-triazolyl, thiazolyl, 1,2,3,4-tetrazolyl, benzimidazolyl, quinazolyl, 2,4-dihydroquinazolyl, and 3H,4H-1,3,4-benzotriazepinyl, and when m is 0, R.sup.3 may also be a group of the formula:
- --NR.sup.6 R.sup.7 wherein R.sup.6 is hydrogen, a lower alkyl or a phenyl llower)alkyl, and R.sup.7 is hydrogen, a lower alkyl, a group --CZ--NHR.sup.8 (Z is sulfur or an imino which may be substituted with a lower alkyl, and R.sup.8 is a lower alkyl or imino), a tetrazolyl which may have a lower alkyl substituent, or a group --CO--R.sup.9, wherein R.sup.9 is a lower alkyl, a phenyl which may have 1 to 3 lower alkoxy substituents, a cycloalkyl or a 5- or 6-membered unsaturated heterocyclic group containing one hetero atom selected from nitrogen and oxygen, which group is pyridyl, pyranyl, pyrrolyl or furyl, or the R.sup.6 and R.sup.7 may combine together with the nitrogen atom to which they are joined to form a group ##STR35## in said formula --B--CO--R.sup.4, B is a lower alkylene, and R.sup.4 is a group of the formula:
- --NR.sup.10 R.sup.11 wherein R.sup.10 and R.sup.11 are the same or different and are each a lower alkyl (which may have a substituent selected from the group consisting of hydroxy, furyl, pyridyl, phenyl and a phenyl having 1 to 2 lower alkoxy substituents), a cycloalkyl (which may have a substituent selected from the group consisting of hydroxy or a lower alkoxy), a phenyl (which may have 1 to 2 substituents selected from the group consisting of a lower alkyl, a lower alkoxy, a halogen, nitro, carboxy and a lower alkylamino), or a thiazolyl, or the R.sup.10 and R.sup.11 may combine together with the nitrogen atoms to which they are joined with or without being intervened with nitrogen or oxygen to form a 5- or 6-membered saturated heterocyclic group selected from pyrrolidino, morpholino, 1-piperidyl and 1-piperazinyl which may have a lower alkyl substituent,
- provided that when m is 0, R.sup.3 is not substituted phenyl(lower)alkyl or unsubstituted phenyl,
- and provided that when B is methylene or dimethylmethylene (--C(CH.sub.3).sub.2 --), R.sup.4 excludes di-(lower)alkylamino and 1-piperidyl,
- or a pharmaceutically acceptable salt thereof.
1-phenyl-5-(3-cyclohexylcarbonylpropyl)-thio-1,2,3,4-tetrazole.
1-methyl-5-(2-benzoylethyl)thio-1,2,3,4-tetrazole.
N,N-diethyl-4-(5-methyl-1,2,3,4-tetrazol-1-yl)butyramide.
N,N-dipropyl-4-(5-methyl-1,2,3,4-tetrazol-1-yl)butyramide.
N,N-diethyl-5-(5-methyl-1,2,3,4-tetrazol-1-yl)valeramide.
N,N-diethyl-4-(5-phenyl-1,2,3,4-tetrazol-1-yl)butyramide.
1-methyl-5-acetylmethylthio-1,2,3,4-tetrazole.
1-methyl-5-[3-(2-pyridyl)carbonylpropyl]thio-1,2,3,4-tetrazole.
1-methyl-5-[3-(2-amino-4-thiazolyl)methylthiopropyl]thio-1,2,3, 4-tetrazole.
An anti-ulcer composition, which comprises as active ingredient an effective amount of a tetrazole derivative of the formula:
- ##STR40## wherein R.sup.1 is a lower alkyl, phenyl or a group of the formula:
- --S(O).sub.l --A--(X).sub.m --R.sup.3, and R.sup.2 is hydrogen, a lower alkyl, phenyl or a cycloalkyl when R.sup.1 is the group --S(O).sub.l --A--(X).sub.m --R.sup.3, or R.sup.2 is a group of the formula:
- --B--CO--R.sup.4 when R.sup.1 is a lower alkyl or phenyl;
- in said formula --S(O).sub.l --A--(X).sub.m --R.sup.3, X is --CO-- or S--(O).sub.n --, l and n are each 0, 1 or 2, m is 0 or 1, A is an alkylene having 1 to 8 carbon atoms, and R.sup.3 is a lower alkyl, a cycloalkyl, naphthyl, a group of the formula:
- ##STR41## (R.sup.5 is a lower alkyl), a phenyl(lower)alkyl which may have a halogen substituent on the phenyl ring, a phenyl which may have 1 to 3 substituents selected from the group consisting of a halogen, a lower alkyl, a lower alkoxy, a lower alkanoylamino, hydroxy, carboxy and amino, a heterocyclic group-substituted lower alkyl which may have a substituent selected from a lower alkyl and amino wherein the heterocyclic group is selected from pyridyl, furyl and thiazolyl, or a heterocyclic group containing 1 to 4 hetero atoms selected from nitrogen, oxygen and sulfur which may have 1 to 2 substituents selected from the group consisting of a lower alkyl, a halogen, carboxy, oxo, amino, a lower alkoxycarbonyl, a lower alkoxy, hydroxy, nitro, phenyl, a cycloalkyl and a lower alkylamino, wherein the heterocyclic group containing 1 to 4 hetero atoms is selected from thienyl, furyl, pyrrolyl, pyridyl, pyranyl, pyrimidyl, quinolyl, 1,2,3,4-tetrahydroquinolyl, imidazolyl, 1,3,4-thiadiazolyl, 1,3,4-oxadiazolyl, 1H-1,2,4-triazolyl, 4H-1,2,4-triazolyl, thiazolyl, 1,2,3,4-tetrazolyl, benzimidazolyl, quinazolyl, 2,4-dihydroquinazolyl, and 3H,4H-1,3,4-benzotriazepinyl, and when m is 0, R.sup.3 may also be a group of the formula:
- --NR.sup.6 R.sup.7 wherein R.sup.6 is hydrogen, a lower alkyl or a phenyl(lower)alkyl, and R.sup.7 is hydrogen, a lower alkyl, a group --CZ--NHR.sup.8 (Z is sulfur or an imino which may be substituted with a lower alkyl, and R.sup.8 is a lower alkyl or amino, a tetrazolyl which may have a lower alkyl substituent, or a group --CO--R.sup.9, wherein R.sup.9 is a lower alkyl, a phenyl which may have 1 to 3 lower alkoxy substituents, a cycloalkyl or a 5- or 6-membered unsaturated heterocyclic group containing one hetero atom selected from nitrogen and oxygen, said group being pyrrolidino, morpholino, 1-piperidinyl or 1-piperazinyl, or the R.sup.6 and R.sup.7 may combine together with the nitrogen atom to which they are joined to form a group ##STR42## in said formula --B--CO--R.sup.4, B is a lower alkylene, and R.sup.4 is a group of the formula:
- --NR.sup.10 R.sup.11 wherein R.sup.10 and R.sup.11 are the same or different and are each a lower alkyl (which may have a substituent selected from the group consisting of hydroxy, furyl, pyridyl, phenyl and a phenyl having 1 to 2 lower alkoxy substituents), a cycloalkyl (which may have a substituent selected from the group consisting of hydroxy or a lower alkoxy), a phenyl (which may have 1 to 2 substituents selected from the group consisting of a lower alkyl, a lower alkoxy, a halogen, nitro, carboxy and a lower alkylamino), or a thiazolyl, or the R.sup.10 and R.sup.11 may combine together with the nitrogen atom to which they are joined with or without being intervened with nitrogen or oxygen to form a 5- or 6-membered saturated heterocyclic group which may have a lower alkyl substituent, provided that when m is 0, R.sup.3 is not unsubstituted phenyl(lower)alkyl or unsubstituted phenyl, and provided that when B is methylene or dimethylmethylene (--C(CH.sub.3).sub.2 --), R.sup.4 excludes di-(lower)alkylamino and 1-piperidyl, or a pharmaceutically acceptable salt thereof in admixture with a carrier or diluent.
Dependencies are inferred from the claim text.